Results 91 to 100 of about 1,452 (123)

Effects of D-Chiro-Inositol on Glucose Metabolism in db/db Mice and the Associated Underlying Mechanisms. [PDF]

Front Pharmacol, 2020
Fan C, Liang W, Wei M, Gou X, Han S, Bai J.   +5 more
europepmc   +1 more source

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review. [PDF]

J Clin Med, 2020
Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R.   +4 more
europepmc   +1 more source

Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome. [PDF]

Nutrients
Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, Soresi M, Veronese N, Barbagallo M, Giannitrapani L.   +8 more
europepmc   +1 more source

D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome. [PDF]

Int J Mol Sci, 2020
Pericuesta E, Laguna-Barraza R, Ramos-Ibeas P, Gutierrez-Arroyo JL, Navarro JA, Vera K, Sanjuan C, Baixeras E, de Fonseca FR, Gutierrez-Adan A.   +9 more
europepmc   +1 more source

Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports. [PDF]

Clin Med Insights Case Rep
Armijo-Sánchez A, Benítez Castillo N, García-Vidal E, Luna Chadid M, Salvador Ballada C, Valls Ricart G, Torres Pellens V.   +6 more
europepmc   +1 more source

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. [PDF]

J Ovarian Res, 2019
Troisi J, Cinque C, Giugliano L, Symes S, Richards S, Adair D, Cavallo P, Sarno L, Scala G, Caiazza M, Guida M.   +10 more
europepmc   +1 more source

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. [PDF]

Cochrane Database Syst Rev, 2017
Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH.   +4 more
europepmc   +1 more source

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.

Gynecol Obstet Invest
Pustotina O, Myers SH, Unfer V, Rasulova I.   +3 more
europepmc   +1 more source

D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress. [PDF]

Acta Pharmacol Sin, 2018
Zhao SS, Li NR, Zhao WL, Liu H, Ge MX, Zhang YX, Zhao LY, You XF, He HW, Shao RG.   +9 more
europepmc   +1 more source

d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).

Gynecol Obstet Invest
Dinicola S, Unfer V, Soulage CO, Yap-Garcia MIM, Bevilacqua A, Benvenga S, Barbaro D, Wdowiak A, Nordio M, Dewailly D, Appetecchia M, Aragona C, Espinola MSB, Bizzarri M, Cavalli P, Colao A, D'Anna R, Vazquez-Levin MH, Hernàndez Marin I, Kamenov Z, Laganà AS, Monastra G, Montanino Oliva M, Cenk Özay A, Pintaudi B, Porcaro G, Pustotina O, Pkhaladze L, Prapas N, Roseff S, Salehpour S, Stringaro A, Tugushev M, Unfer V, Vucenik I, Facchinetti F.   +35 more
europepmc   +1 more source